Literature DB >> 11859478

New lupane glycosides from Pulsatilla chinensis.

Wencai Ye, Qingwen Zhang, Wendy W Hsiao, Shouxun Zhao, Chun-Tao Che.   

Abstract

Two new lupane glycosides along with five known triterpenoids were isolated from the roots of Pulsatilla chinensis (Ranunculaceae). The structures of the new glycosides were determined to be 3-O-beta-D-glucopyranosyl(1-->3)-alpha-L-arabinopyranosyl-23-hydroxybetulinic acid 28-O-alpha-L-rhamnopyranosyl(1-->4)-beta-D-glucopyranosyl(1-->6)-beta-D-glucopyranosyl ester (pulsatilloside D, 6) and 3-O-[beta-D-glucopyranosyl(1-->4)][alpha-L-rhamnopyranosyl(1-->2)]-alpha-L-arabinopyranosyl-23-hydroxybetulinic acid 28-O-alpha-L-rhamnopyranosyl(1-->4)-beta-D-glucopyranosyl(1-->6)-beta-D-glucopyranosyl ester (pulsatilloside E, 7) by spectroscopic analysis and chemical methods. The compounds were evaluated for cytotoxic activities against K-562 human leukemia and HeLa cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11859478     DOI: 10.1055/s-2002-20254

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  4 in total

Review 1.  Pharmacological activities and molecular mechanisms of Pulsatilla saponins.

Authors:  Jinmiao Zhong; Lihua Tan; Meiwan Chen; Chengwei He
Journal:  Chin Med       Date:  2022-05-23       Impact factor: 4.546

2.  Extracts from Pulsatilla patens target cancer-related signaling pathways in HeLa cells.

Authors:  Grażyna Łaska; Magdalena Maciejewska-Turska; Elwira Sieniawska; Łukasz Świątek; David S Pasco; Premalatha Balachandran
Journal:  Sci Rep       Date:  2021-05-20       Impact factor: 4.379

3.  Rapidly discriminate commercial medicinal Pulsatilla chinensis (Bge.) Regel from its adulterants using ITS2 barcoding and specific PCR-RFLP assay.

Authors:  Yuhua Shi; Mingming Zhao; Hui Yao; Pei Yang; Tianyi Xin; Bin Li; Wei Sun; Shilin Chen
Journal:  Sci Rep       Date:  2017-01-06       Impact factor: 4.379

Review 4.  Pulsatilla chinensis (Bge.) Regel: A Systematic Review on Anticancer of Its Pharmacological Properties, Clinical Researches and Pharmacokinetic Studies.

Authors:  Hang Li; Lilan Wang; Xiaojing Zhang; Wenxin Xia; Xirong Zhou; Hong Sui; Xueyan Fu
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.